| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8632896 | Metabolism | 2018 | 46 Pages |
Abstract
To our knowledge, our work might be the first report on the mechanism underlying FXR antagonist in the regulation of gluconeogenesis, and all results have also highlighted the potential of HS218 in the treatment of T2DM.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Xin Xu, Xiaofan Shi, Yidi Chen, Tingting Zhou, Jiaying Wang, Xing Xu, Lili Chen, Lihong Hu, Xu Shen,